Office of Professional Education

Beginning Tuesday, August 24, 2021 • CME Credit for Zoom Webinar and Twitter Chat participants

  • Article Summary: Link will be posted here a week prior to the webinar.
    • Amikacin liposome inhalation suspension for Treatment-Refractory lung disease caused by Mycobacterium avium complex (CONVERT).  A prospective, open-label, randomized study. Am J Repir Crit Care Med 2018; 198: 1559-1569. 
    • Faculty Host and Lead Author of the Article: David E. Griffith, MD
  • Zoom Webinar with CME credit: REGISTER.
    • Tuesday, August 24, 2021
    • 11:30 am (PT) / 12:30 pm (MT) / 1:30 pm (CT) / 2:30 pm (ET)
    • 30-minutes, once a month. Check here for upcoming dates and times.
    • Expert faculty summarize a journal article and lead an academic and peer discussion on new data with Q&A time.
  • Twitter Chat @NJHealthMedEd with CME credit: Add to Calendar
    • Wednesday, August 25, 2021
    • 6:00 pm (PT) / 7:00 pm (MT) / 8:00 pm (CT) / 9:00 pm (ET)
    • 30-minutes, once a month. Check here for upcoming dates and times.
    • Expert faculty lead the Chat about the article summary to facilitate an academic and peer discussion on new data with Q&A.
    • To join the discussion, go to Twitter, type in #NTMTwitterJC and click on the “Latest” tab
    • Please use this hashtag when posting: #NTMTwitterJC
    • Twitter Chat Instructions
  • Recorded webinars will be available at


Target Audience:

Pulmonologists, Infectious Disease Physicians, Primary Care and Family Medicine Physicians, Physician Assistants, and Advanced Practice Nurses who treat patients with NTM.


Program Chairs:

Charles L Daley MD

Charles L. Daley, MD
Chief, Division of Mycobacterial and Respiratory Infections
Professor of Medicine
University of Colorado Denver
National Jewish Health
Denver, CO

Shannon H. Kasperbauer MD
Shannon H. Kasperbauer, MD
Associate Professor of Medicine
Division of Mycobacterial and Respiratory Infections
National Jewish Health
University of Colorado Denver
Denver, CO


Learning Objectives:

Upon completion of this activity, the participant will be better able to:

  • Apply critical thinking for research analysis in the review of new data and guidelines in NTM.
  • Utilize increased awareness and understanding of research, evidence and best practices to inform clinical practice in NTM.
  • Support an online community of practitioners to share key insights, latest research, and treatment strategies for patients with NTM.



For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email


Accreditation and Designation Statements:

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Jewish Health designates each live activity for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Supported by an Educational Grant from Insmed.